Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Redefining the minimal antigen-binding fragment.

Literature DB >> 8784342

Redefining the minimal antigen-binding fragment.

S Sheriff, K L Constantine.

Abstract

Mesh：

Substances：

Year: 1996 PMID： 8784342 DOI： 10.1038/nsb0996-733

Source DB: PubMed Journal: Nat Struct Biol ISSN： 1072-8368

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. Isolation and characterization of monoclonal antibodies that inhibit hepatitis C virus NS3 protease.

Authors: T Ueno; S Misawa; Y Ohba; M Matsumoto; M Mizunuma; N Kasai; K Tsumoto; I Kumagai; H Hayashi
Journal: J Virol Date: 2000-07 Impact factor: 5.103

2. Potent enzyme inhibitors derived from dromedary heavy-chain antibodies.

Authors: M Lauwereys; M Arbabi Ghahroudi; A Desmyter; J Kinne; W Hölzer; E De Genst; L Wyns; S Muyldermans
Journal: EMBO J Date: 1998-07-01 Impact factor: 11.598

3. A llama-derived gelsolin single-domain antibody blocks gelsolin-G-actin interaction.

Authors: Anske Van den Abbeele; Sarah De Clercq; Ariane De Ganck; Veerle De Corte; Berlinda Van Loo; Sameh Hamdy Soror; Vasundara Srinivasan; Jan Steyaert; Joël Vandekerckhove; Jan Gettemans
Journal: Cell Mol Life Sci Date: 2010-02-07 Impact factor: 9.261

Redefining the minimal antigen-binding fragment.

1. Isolation and characterization of monoclonal antibodies that inhibit hepatitis C virus NS3 protease.

2. Potent enzyme inhibitors derived from dromedary heavy-chain antibodies.

3. A llama-derived gelsolin single-domain antibody blocks gelsolin-G-actin interaction.

4. The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions.

5. Novel antibody derivatives for proteome and high-content analysis.

6. The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi.

7. A novel VHH antibody targeting the B cell-activating factor for B-cell lymphoma.